Acute transverse myelitis

被引：3

作者：

de Seze, J. ^{[1
]}

机构：

[1] CHU Strasbourg, Neurol Clin, F-67091 Strasbourg, France

来源：

REVUE DE MEDECINE INTERNE | 2009年 / 30卷 / 12期

关键词：

Acute transverse myelopathy; Systemic diseases; MRI; CSF; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DEVICS-NEUROMYELITIS-OPTICA; SPINAL-CORD; MULTIPLE-SCLEROSIS; IMAGING FINDINGS; INTERFERON; MYELOPATHY; THERAPY; DIAGNOSIS; MARKER;

D O I：

10.1016/j.revmed.2009.03.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Acute transverse myelopathy (ATM) is a large group from various etiologies including multiple sclerosis, systemic diseases, post-infectious myelopathy, spinal cord infarct and neuromyelitis optica. In about 20% of cases, the etiology remains unknown even after a long-term follow-up. We call these cases "idiopathic ATM". The poor prognosis of ATM makes necessary an early diagnosis to avoid therapeutic delay. The aim of this review is to describe clinical and laboratory data concerning ATM allowing to improve diagnostic and therapeutic approaches. (C) 2009 Societe nationale francaise de medecine interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.

引用

页码：1030 / 1037

页数：8

共 37 条

[1]

Albayram S, 2002, AM J NEURORADIOL, V23, P1603

[2]

Angibaud G, 1995, REV NEUROL-FRANCE, V151, P661

[3] Proposed diagnostic criteria and nosology of acute transverse myelitis [J].

Barnes, G ;

Benjamin, S ;

Bowen, JD ;

Cutter, N ;

de Lateur, BJ ;

Dietrich, WD ;

Dowling, MM ;

Griffin, JW ;

Hummers, L ;

Irani, D ;

Jorens, PG ;

Kaplin, AI ;

Katz, JD ;

Kerr, DA ;

Krishnan, C ;

Levy, CE ;

Lucchinetti, C ;

Lynn, DJ ;

Mandler, RN ;

McArthur, JC ;

McDonald, JW ;

Morrison, L ;

Pardo-Villamizar, C ;

Pidcock, FS ;

Ransohoff, R ;

Roos, KL ;

Trovato, MK ;

Vollmer, TL ;

Wegener, ST ;

Weinshenker, BG ;

Wingerchuk, DM .

NEUROLOGY, 2002, 59 (04) :499-505

[4] Infectious myelopathies [J].

Berger, JR ;

Sabet, A .

SEMINARS IN NEUROLOGY, 2002, 22 (02) :133-141

[5]

Breteau G, 2000, REV NEUROL, V156, P786

[6] Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study [J].

Comi, G ;

Filippi, M ;

Barkhof, F ;

Durelli, L ;

Edan, G ;

Fernández, O ;

Hartung, HP ;

Seeldrayers, P ;

Sorensen, PS ;

Rovaris, M ;

Martinelli, V ;

Hommes, OR .

LANCET, 2001, 357 (9268) :1576-1582

[7] Prospective study of patients presenting with acute partial transverse myelopathy [J].

Cordonnier, C ;

de Seze, J ;

Breteau, G ;

Ferriby, D ;

Michelin, E ;

Stojkovic, T ;

Pruvo, JP ;

Vermersch, P .

JOURNAL OF NEUROLOGY, 2003, 250 (12) :1447-1452

[8] An open label study of the effects of rituximab in neuromyelitis optica [J].

Cree, BAC ;

Lamb, S ;

Morgan, K ;

Chen, A ;

Waubant, E ;

Genain, C .

NEUROLOGY, 2005, 64 (07) :1270-1272

[9] Idiopathic acute transverse myelitis: Application of the recent diagnostic criteria [J].

de Seze, J ;

Lanctin, C ;

Lebrun, C ;

Malikova, I ;

Papeix, C ;

Wiertlewski, S ;

Pelletier, J ;

Gout, O ;

Clerc, C ;

Moreau, C ;

Defer, G ;

Edan, G ;

Dubas, F ;

Vermersch, P .

NEUROLOGY, 2005, 65 (12) :1950-1953

[10] Acute myelopathies -: Clinical, laboratory and outcome profiles in 79 cases [J].

de Seze, J ;

Stojkovic, T ;

Breteau, G ;

Lucas, C ;

Michon-Pasturel, U ;

Gauvrit, JY ;

Hachulla, E ;

Mounier-Vehier, F ;

Pruvo, JP ;

Leys, D ;

Destée, A ;

Hatron, PY ;

Vermersch, P .

BRAIN, 2001, 124 :1509-1521

← 1 2 3 4 →